BioWorld

Jan. 8, 1991

View Archived Issues

HAMBRECHT AND QUIST CONFERENCE BRIEFS:

Read More

NEWS BRIEFS

Read More

ADVANCEMENTS AND APPOINTMENTS

Read More

REPLIGEN LICENSES ANTI-INFLAMMATORY MAb

Read More

XOMA PREDICTS BREAK-EVEN RESULTS IN 1991

Read More

AMGEN EXPECTS NEUPOGEN TO GET NOD

Read More

GENENTECH SIGNS $15M PACT WITH GLYCOMED

Read More